To CANCER IMMUNITY Home Page

Table 1

HLA types of cervical cancer patients from whom HPV-16-positive primary tumor cell lines were derived and of subjects with a history of HPV 16 infection.

Source

Histology

Class I

Class II

Patient 1

squamous cell

A1, A2, 3501, 5701, Cw6

DR1, DR3, DR7, DR53, DQ5, DQ9

Patient 2

squamous cell

A30, 5301, 5703, Cw4, Cw7

DR13, DR15, DQ2, DQ6, DR51, DR52

Patient 3

squamous cell

A1, A2, 5001, 5701, Cw6

DR3, DR7, DR53, DQ2, DQ9

Subject 1

NA

A2, A68, 4001, 5703, Cw3, Cw6

ND

Subject 2

NA

A2, A32, 1501, 5701, Cw3, Cw6

ND

Subject 3

NA

A1, A2, 0702, 5701, Cw6, Cw7

ND

Abbreviations: NA, not applicable; ND, not done.

 

Copyright © 2006 by Mayumi Nakagawa